Industry Background:
A centrifugal blood pump, also known as a cardiotomy suction system is used during cardiopulmonary bypass cardiac surgery that pumps blood through the extracorporeal bypass circuit to provide extracorporeal circulatory support. Extracorporeal life support technology has given intensive care management of acute cardiac and respiratory failure in neonates, children, and adults who have failed traditional treatment a new advanced dimension. Manufacturers are concentrating on designing cost-effective extracorporeal circulatory devices for cardiopulmonary bypass surgeries. The demand for extracorporeal support systems is expected to increase, which will boost the demand for centrifugal blood pumps. Extracorporeal blood pumps have been developed to meet a range of paediatric health needs. The manufacturer is constantly developing new procedures and equipment in response to complications in cardiopulmonary bypass surgeries.
According to AMA Research, the market for Centrifugal Blood Pump is expected to register a CAGR of 5.3% during the forecast period to 2027. This growth is primarily driven by The Rapid Increase in Health Problems like Heart Diseases around the World
.
Attributes | Details |
---|
Study Period | 2017-2027 |
Base Year | 2021 |
Forecast Period | 2022-2027 |
Volume Unit | K Units |
Value Unit | Value (USD Million) |
Key Companies in Study | Medtronic Plc (Ireland), Thoratec Corporation (United States), Terumo Corporation (Japan), Braile Biomedica Ltd. (Brazil), LivaNova, PLC (United Kingdom), Fresenius Medical Care Company (Germany), Getinge AB (Sweden), Baxter International (United States), Kyocera Corporation (Japan), 3-M Health Care (United States) and St. Jude Medical, Inc (United States) |
Customization Scope | Avail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility |
The Health Care Equipment sector in the
region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Medtronic Plc (Ireland), Thoratec Corporation (United States), Terumo Corporation (Japan), Braile Biomedica Ltd. (Brazil), LivaNova, PLC (United Kingdom), Fresenius Medical Care Company (Germany), Getinge AB (Sweden), Baxter International (United States), Kyocera Corporation (Japan), 3-M Health Care (United States) and St. Jude Medical, Inc (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.
In 2020, The US FDA has approved a device called the Quantum PureFlow centrifugal blood pump. It was published by Kura S.r.l.Manufacturers of centrifugal blood pumps are pursuing strategic partnerships with service providers in order to meet the needs of an ever-growing patient population. They expect to improve their position in the market by acquiring, partnering with, and establishing alliances with small and medium-sized manufacturers.
Regulatory Insights:
The World Health Organization (WHO) predicts that heart disease will remain the leading cause of death worldwide. Heart disease has been the leading cause of death worldwide over the past 20 years. But now we are killing more people than ever before. The number of deaths from heart disease has increased by more than 2 million since 2000, reaching nearly 9 million in 2019.
Market Drivers
- The Rapid Increase in Health Problems like Heart Diseases around the World
- Increasing In Geriatric Population
Market Trend
- Introduction of Third-Generation Ventricular Assist Devices
Opportunities
Increasing Investment on Healthcare Infrastructure
Challenges
Availability of Low Cost Alternatives
AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.
Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
Against this Challenging Backdrop, Centrifugal Blood Pump Study Sheds Light on
The Centrifugal Blood Pump Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Centrifugal Blood Pump industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
Where Centrifugal Blood Pump industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey, and interviews with key executives and industry experts.
How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.